Consumer Perceptions of Safety Information in Direct-to-Consumer Print Advertisements for Alzheimer Drugs

Author:

Markell Jenny1,Odouard Ilina1,Anderson Gerard F.1,DiStefano Michael J.2

Affiliation:

1. Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland

2. Center for Pharmaceutical Outcomes Research, Department of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora

Abstract

This survey study assesses the effectiveness of drug advertisement to shape perception of the benefits and risks of and personal willingness to use and recommend an advertised drug.

Publisher

American Medical Association (AMA)

Reference6 articles.

1. Communicating benefit and risk information in direct-to-consumer print advertisements: a randomized study.;Sullivan;Ther Innov Regul Sci,2015

2. Alzheimer’s disease: lecanemab gets full FDA approval and black box safety warning.;Mahase;BMJ,2023

3. Consumer responses to price disclosure in direct-to-consumer pharmaceutical advertising.;Garrett;JAMA Intern Med,2019

4. Lecanemab in early Alzheimer’s disease.;van Dyck;N Engl J Med,2023

5. US Food and Drug Administration. Presenting quantitative efficacy and risk information in direct-to-consumer (DTC) promotional labeling and advertisements. Updated December 2023. Accessed January 15, 2024. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/presenting-quantitative-efficacy-and-risk-information-direct-consumer-dtc-promotional-labeling-and

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3